Northeast Georgia Medical Center, INC.

Northeast Georgia Medical Center, INC. was paid $112.63M by Medicaid between Jan 2018 and Dec 2024, across 580 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.

33Billing provider infoNORTHEAST GEORGIA MEDICAL CENTER, INC.
GAINESVILLE, GA 30501

33aNPI1427055821assigned 06/30/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$112.63M

24GClaims3,277,629

24DCodes billed580

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Georgia

Rank by total paid#1 of 34

Median peer was paid$23K

This provider vs. median4,881×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	525,581	$16.89M
2019	499,427	$15.59M
2020	390,002	$13.38M
2021	472,922	$17.60M
2022	498,389	$18.46M
2023	518,408	$18.75M
2024incomplete	372,900	$11.97M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	63,177	56,660	$14.49M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	11%	71,053	64,520	$12.35M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	8.0%	31,236	27,861	$8.98M
99282	Emergency department visit for the evaluation and management, low to moderate severity	4.6%	38,325	35,553	$5.20M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.3%	15,030	14,120	$4.84M
96361	Intravenous infusion, hydration; each additional hour	2.7%	50,031	36,014	$3.08M
G0378	Hospital observation service, per hour	2.6%	22,054	20,134	$2.88M
0202U	Oncology (prostate), multianalyte, gene expression profiling	2.5%	8,605	8,239	$2.81M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.9%	11,192	10,641	$2.11M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	1.8%	20,831	19,610	$2.00M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.4%	6,832	6,431	$1.61M
96375	Therapeutic injection; each additional sequential IV push	1.4%	45,184	35,653	$1.60M

568 more codes

U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.4%	19,380	$1.57M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	23,711	$1.56M
70450	Computed tomography, head or brain; without contrast material	1.3%	13,974	$1.46M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.2%	49,535	$1.38M
78815	Positron emission tomography (PET) for limited area imaging	1.1%	1,563	$1.29M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.1%	3,128	$1.21M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.1%	67,281	$1.20M
59025	Fetal non-stress test	1.0%	11,462	$1.14M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	43,042	$1.06M
71046	Radiologic examination, chest; 2 views	<1%	23,868	$1.04M
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,290	$928K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	11,480	$832K
80053	Comprehensive metabolic panel	<1%	143,426	$816K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	10,814	$806K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	30,595	$731K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,125	$727K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	22,193	$654K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,848	$622K
36415	Collection of venous blood by venipuncture	<1%	44,843	$614K
71045	Radiologic examination, chest; single view	<1%	43,069	$604K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	157,132	$603K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	3,766	$596K
70496		<1%	2,598	$588K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,380	$578K
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	<1%	1,575	$572K
70498		<1%	2,926	$566K
47562		<1%	556	$559K
96376		<1%	17,271	$553K
77336		<1%	3,827	$539K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	4,600	$522K
93458		<1%	694	$483K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,544	$463K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,306	$429K
93017		<1%	5,205	$428K
J7030	Infusion, normal saline solution , 1000 cc	<1%	49,501	$420K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,702	$417K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,521	$398K
72141		<1%	2,218	$384K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	9,747	$376K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	607	$376K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	10,840	$374K
49083		<1%	1,678	$353K
77412		<1%	3,262	$323K
93970		<1%	2,918	$316K
84484		<1%	59,192	$310K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	33,566	$304K
77334		<1%	1,304	$290K
76770		<1%	2,887	$284K
93971		<1%	3,437	$274K
71250		<1%	2,605	$269K
J2785	Injection, regadenoson, 0.1 mg	<1%	4,445	$265K
82553		<1%	43,013	$243K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	13,723	$242K
96367		<1%	3,890	$239K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,529	$230K
87070		<1%	23,790	$227K
D9420		<1%	406	$225K
93880		<1%	3,197	$224K
84443	Thyroid stimulating hormone (TSH)	<1%	21,241	$224K
76830	Ultrasound, transvaginal	<1%	3,033	$222K
77300		<1%	913	$220K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	14,249	$220K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	16,532	$213K
82803		<1%	19,532	$198K
97161		<1%	8,325	$197K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,786	$194K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,143	$191K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,473	$187K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	18,463	$177K
83880		<1%	9,343	$177K
99213	Doctor's office visit, returning patient (routine)	<1%	4,769	$176K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	7,222	$174K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	7,148	$171K
99152		<1%	7,698	$164K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,595	$158K
87088		<1%	28,845	$156K
88342		<1%	4,825	$155K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	550	$155K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	4,055	$153K
73610		<1%	3,407	$151K
83735		<1%	49,238	$148K
73030		<1%	3,291	$148K
73130		<1%	3,075	$144K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	6,170	$140K
78227		<1%	365	$140K
12001		<1%	1,863	$139K
84703		<1%	40,257	$135K
36430		<1%	937	$133K
72100		<1%	2,386	$131K
72131		<1%	1,148	$130K
73630		<1%	3,517	$130K
88307		<1%	2,593	$126K
80048	Basic metabolic panel (calcium, ionized)	<1%	30,643	$125K
73564		<1%	3,210	$124K
74018		<1%	5,527	$122K
APT15		<1%	10,208	$120K
J3490	Unclassified drugs	<1%	26,518	$120K
81001		<1%	56,858	$119K
76536		<1%	1,293	$115K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,958	$115K
93356		<1%	2,221	$114K
73110		<1%	2,334	$114K
83690		<1%	31,629	$110K
47563		<1%	99	$110K
96368		<1%	1,881	$109K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	24,563	$108K
74183		<1%	458	$107K
70486		<1%	1,029	$107K
86850		<1%	13,529	$107K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	7,115	$106K
83605		<1%	22,688	$106K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,432	$101K
87631		<1%	2,251	$97K
97014		<1%	8,367	$97K
58661		<1%	130	$96K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,578	$95K
73590		<1%	1,831	$93K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	24,931	$93K
64488		<1%	1,683	$90K
87077		<1%	15,083	$90K
80061	Lipid panel	<1%	18,752	$88K
93925		<1%	1,197	$88K
88341		<1%	5,063	$85K
73090		<1%	1,973	$84K
82550		<1%	51,265	$84K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,566	$84K
84702		<1%	15,442	$82K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	16,959	$82K
70491		<1%	398	$81K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	485	$78K
12011		<1%	1,588	$77K
97162		<1%	3,343	$77K
72040		<1%	1,372	$74K
93325		<1%	1,732	$73K
82607		<1%	7,501	$72K
85027		<1%	21,307	$71K
77066	Tomosynthesis, mammo	<1%	1,249	$70K
84439		<1%	13,703	$70K
J1815	Injection, insulin, per 5 units	<1%	7,974	$69K
85730		<1%	25,325	$69K
J2704	Injection, propofol, 10 mg	<1%	25,660	$68K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	852	$68K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	532	$67K
81003		<1%	29,835	$67K
93320		<1%	876	$66K
86901		<1%	18,313	$65K
87430		<1%	12,267	$65K
76870		<1%	653	$64K
73502		<1%	2,016	$64K
82330		<1%	19,458	$64K
85610		<1%	33,013	$63K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,939	$63K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,482	$61K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,919	$60K
77301		<1%	44	$59K
87040		<1%	15,732	$57K
APT17		<1%	3,803	$56K
87186		<1%	10,586	$56K
93351		<1%	221	$55K
82731		<1%	880	$55K
APT16		<1%	3,931	$54K
C1769	Guide wire	<1%	6,353	$52K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	118	$51K
72110		<1%	664	$50K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	922	$50K
86900		<1%	18,330	$49K
88304		<1%	3,236	$49K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	477	$49K
76937		<1%	767	$46K
J7050	Infusion, normal saline solution, 250 cc	<1%	26,042	$45K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	251	$44K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,348	$44K
44970		<1%	31	$43K
73552		<1%	964	$43K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	3,469	$42K
82728		<1%	4,885	$42K
86403		<1%	1,401	$41K
12002		<1%	665	$41K
74022		<1%	676	$41K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	556	$40K
73221		<1%	213	$39K
85379		<1%	7,924	$39K
80074		<1%	1,258	$39K
95811		<1%	55	$39K
81025		<1%	4,974	$37K
93923		<1%	528	$37K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,326	$36K
74178		<1%	119	$36K
J8501	Aprepitant, oral, 5 mg	<1%	1,042	$36K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	34,440	$36K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	15,985	$36K
76642		<1%	1,562	$35K
82746		<1%	4,242	$34K
82077		<1%	5,489	$34K
73560		<1%	1,536	$34K
58571		<1%	55	$34K
90715		<1%	2,233	$33K
86140		<1%	11,725	$33K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,563	$33K
73060		<1%	722	$33K
95816		<1%	186	$30K
75574		<1%	147	$30K
78431		<1%	898	$29K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	51,543	$29K
J1756	Injection, iron sucrose, 1 mg	<1%	1,330	$28K
95819		<1%	153	$28K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	578	$28K
73080		<1%	741	$27K
73070		<1%	600	$26K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	14,116	$26K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	722	$26K
99153	Mod sedat endo service >5yrs	<1%	2,624	$26K
99215	Doctor's office visit, returning patient (complex)	<1%	559	$25K
82565		<1%	20,751	$25K
76641		<1%	457	$25K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	298	$24K
83550		<1%	4,245	$24K
97116		<1%	4,890	$24K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	15,077	$23K
J3480	Injection, potassium chloride, per 2 meq	<1%	6,483	$23K
94060		<1%	308	$23K
J0690	Injection, cefazolin sodium, 500 mg	<1%	14,026	$23K
64415		<1%	823	$22K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,310	$22K
72170		<1%	820	$22K
73140		<1%	396	$22K
83718		<1%	1,898	$22K
72072		<1%	289	$22K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	22,945	$21K
72146		<1%	171	$21K
84112		<1%	375	$21K
D7140	Extraction, erupted tooth or exposed root	<1%	153	$21K
97165		<1%	1,624	$20K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	610	$20K
86923		<1%	1,473	$20K
93308		<1%	430	$20K
86803		<1%	2,250	$19K
94664		<1%	1,577	$19K
0399T		<1%	698	$19K
83540		<1%	4,393	$19K
87340		<1%	2,201	$18K
80069		<1%	4,694	$18K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	7,830	$18K
51701		<1%	1,139	$18K
75625		<1%	50	$18K
J1170	Injection, hydromorphone, up to 4 mg	<1%	11,392	$17K
97597		<1%	429	$17K
93990		<1%	734	$17K
74174		<1%	57	$17K
86762		<1%	1,421	$16K
73100		<1%	217	$16K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	5,111	$16K
94729		<1%	296	$15K
77065	Tomosynthesis, mammo	<1%	572	$15K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,911	$15K
52356		<1%	16	$15K
93321		<1%	523	$15K
84132		<1%	22,613	$15K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	25,038	$15K
82435		<1%	18,371	$15K
C9399	Unclassified drugs or biologicals	<1%	776	$14K
82570		<1%	3,615	$14K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	816	$14K
96417		<1%	201	$14K
36561		<1%	13	$14K
78264		<1%	56	$14K
88112		<1%	720	$14K
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,861	$13K
74019		<1%	274	$13K
88142		<1%	1,043	$13K
87653		<1%	711	$13K
82140		<1%	2,057	$13K
64447		<1%	376	$13K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	3,060	$13K
94644		<1%	1,335	$13K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,733	$13K
84145		<1%	3,378	$12K
94726		<1%	181	$12K
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	1,329	$12K
85520		<1%	3,302	$12K
83615		<1%	4,038	$12K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	8,871	$12K
70360		<1%	377	$12K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,685	$12K
87205		<1%	6,110	$12K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	700	$12K
87427		<1%	995	$12K
82947		<1%	19,039	$12K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	90	$12K
10060		<1%	154	$11K
88173		<1%	270	$11K
73600		<1%	229	$11K
80164		<1%	1,164	$11K
58558		<1%	26	$11K
G0379	Direct admission of patient for hospital observation care	<1%	294	$11K
85652		<1%	6,397	$11K
80143		<1%	1,338	$11K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,257	$10K
C9113	Injection, pantoprazole sodium, per vial	<1%	6,446	$10K
86703		<1%	911	$10K
84295		<1%	18,779	$10K
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	1,965	$10K
73700		<1%	90	$10K
85014		<1%	7,752	$10K
36591		<1%	352	$9K
93225		<1%	156	$9K
77080		<1%	139	$9K
84156		<1%	3,198	$9K
86038		<1%	887	$9K
80179		<1%	1,176	$9K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	281	$9K
80047		<1%	1,218	$9K
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	477	$9K
84550		<1%	3,540	$9K
77386		<1%	236	$9K
87045		<1%	1,030	$8K
71101		<1%	155	$8K
82010		<1%	2,000	$8K
29105		<1%	351	$8K
36600		<1%	697	$8K
77290		<1%	27	$8K
77338		<1%	95	$8K
J3370	Injection, vancomycin hcl, 500 mg	<1%	3,880	$8K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,207	$8K
77280		<1%	32	$7K
C1776	Joint device (implantable)	<1%	168	$7K
86592		<1%	2,229	$7K
J1790	Injection, droperidol, up to 5 mg	<1%	3,277	$7K
D1120	Dental cleaning, child	<1%	131	$7K
82247		<1%	2,126	$7K
85046		<1%	2,595	$7K
84450		<1%	2,130	$7K
J0248	Injection, remdesivir, 1 mg	<1%	43	$7K
C1729	Catheter, drainage	<1%	765	$7K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	545	$7K
C1781	Mesh (implantable)	<1%	279	$7K
83970		<1%	220	$7K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	52	$6K
74246		<1%	77	$6K
82040		<1%	2,165	$6K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	447	$6K
92526		<1%	678	$6K
82248		<1%	2,640	$6K
93226		<1%	156	$6K
97035		<1%	1,035	$6K
95800		<1%	87	$6K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	1,314	$6K
84520		<1%	2,174	$5K
82272		<1%	2,131	$5K
74220		<1%	91	$5K
J1980	Injection, hyoscyamine sulfate, up to 0.25 mg	<1%	449	$5K
10005		<1%	53	$5K
87420		<1%	175	$5K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,006	$5K
51702		<1%	183	$5K
99203	Doctor's office visit, new patient (routine)	<1%	106	$5K
73620		<1%	192	$5K
84481		<1%	341	$5K
84153		<1%	284	$5K
J1953	Injection, levetiracetam, 10 mg	<1%	467	$4K
27447		<1%	17	$4K
72050		<1%	63	$4K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	579	$4K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	48	$4K
77062		<1%	498	$4K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	196	$4K
85018		<1%	3,412	$4K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	2,049	$4K
96415		<1%	239	$4K
76885		<1%	70	$4K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	647	$4K
77012		<1%	43	$4K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,308	$4K
41899	Unlisted procedure, dentoalveolar structures	<1%	27	$4K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	55	$4K
73200		<1%	25	$4K
80055		<1%	126	$4K
95886		<1%	44	$4K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,863	$4K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	14,207	$4K
87081		<1%	814	$4K
97166		<1%	196	$4K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,398	$4K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	954	$4K
36416		<1%	979	$3K
80081		<1%	85	$3K
80076		<1%	706	$3K
D2330		<1%	28	$3K
76819	Fetal biophysical profile; without non-stress testing	<1%	57	$3K
J1644	Injection, heparin sodium, per 1000 units	<1%	10,441	$3K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	35	$3K
97535	Self-care/home management training, each 15 minutes	<1%	1,686	$3K
86308		<1%	1,046	$3K
73562		<1%	29	$3K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	2,913	$3K
82652		<1%	105	$3K
88302		<1%	195	$3K
29125		<1%	136	$3K
J1453	Injection, fosaprepitant, 1 mg	<1%	91	$3K
88313		<1%	105	$3K
80050	General health panel	<1%	2,279	$3K
C1726	Catheter, balloon dilatation, non-vascular	<1%	67	$3K
J2060	Injection, lorazepam, 2 mg	<1%	4,946	$3K
64450		<1%	39	$3K
87075		<1%	373	$3K
82784		<1%	218	$3K
92610		<1%	610	$3K
84100		<1%	3,826	$3K
J2800	Injection, methocarbamol, up to 10 ml	<1%	589	$2K
95911		<1%	13	$2K
72070		<1%	27	$2K
J0456	Injection, azithromycin, 500 mg	<1%	945	$2K
A9578	Injection, gadobenate dimeglumine (multihance multipack), per ml	<1%	497	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,126	$2K
85384		<1%	589	$2K
H0031	Mental health assessment, by non-physician	<1%	28	$2K
J7510	Prednisolone oral, per 5 mg	<1%	2,179	$2K
82950		<1%	623	$2K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	60	$2K
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	383	$2K
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	28	$2K
43249		<1%	12	$2K
93978		<1%	37	$2K
78492		<1%	155	$2K
87493		<1%	290	$2K
87210		<1%	767	$2K
C1758	Catheter, ureteral	<1%	271	$2K
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	636	$2K
97016		<1%	368	$2K
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	29	$2K
D1206	Topical application of fluoride varnish	<1%	51	$2K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	13	$2K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	15	$2K
J0595	Injection, butorphanol tartrate, 1 mg	<1%	598	$2K
L0150	Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)	<1%	13	$2K
80177		<1%	162	$2K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,491	$2K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	97	$2K
83525		<1%	131	$1K
93975		<1%	13	$1K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	923	$1K
J1630	Injection, haloperidol, up to 5 mg	<1%	3,740	$1K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	17	$1K
75710		<1%	14	$1K
J0736	Injection, clindamycin phosphate, 300 mg	<1%	255	$1K
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	702	$1K
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	157	$1K
83930		<1%	412	$1K
87899		<1%	147	$1K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	2,027	$1K
89051		<1%	634	$1K
J3411	Injection, thiamine hcl, 100 mg	<1%	453	$1K
73660		<1%	12	$1K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	347	$1K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	27	$1K
93926		<1%	12	$1K
C1760	Closure device, vascular (implantable/insertable)	<1%	443	$1K
84146		<1%	70	$987.72
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	142	$962.76
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	296	$945.72
77387		<1%	59	$889.10
J0694	Injection, cefoxitin sodium, 1 gm	<1%	96	$870.50
86706		<1%	323	$866.46
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,860	$846.63
APT04		<1%	96	$836.94
J1940	Injection, furosemide, up to 20 mg	<1%	3,348	$797.43
85055		<1%	46	$792.93
APT18		<1%	60	$788.40
87177		<1%	99	$761.62
APT09		<1%	74	$738.42
80320		<1%	306	$724.17
87102		<1%	103	$712.88
86431		<1%	146	$698.36
99204	Doctor's office visit, new patient (more involved)	<1%	14	$628.65
77332		<1%	15	$605.47
J2470	Injection, pantoprazole sodium, 40 mg	<1%	292	$603.81
83516		<1%	67	$600.37
71271		<1%	30	$583.74
C9145	Injection, aprepitant, (aponvie), 1 mg	<1%	32	$577.56
78434		<1%	845	$571.54
94667		<1%	12	$567.83
87641		<1%	58	$564.96
87220		<1%	161	$558.41
94660		<1%	18	$553.35
77061		<1%	122	$545.41
J7999	Compounded drug, not otherwise classified	<1%	1,158	$510.27
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	13	$509.30
85347		<1%	352	$479.71
88172		<1%	43	$475.16
J1171	Injection, hydromorphone, 0.1 mg	<1%	246	$473.92
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	78	$439.80
J1836	Injection, metronidazole, 10 mg	<1%	212	$430.09
97012		<1%	33	$426.60
J2720	Injection, protamine sulfate, per 10 mg	<1%	428	$421.13
82274		<1%	45	$411.99
87338		<1%	32	$410.86
S0028	Injection, famotidine, 20 mg	<1%	331	$375.25
97163		<1%	26	$353.51
83655		<1%	43	$344.21
APT11		<1%	25	$315.12
74230		<1%	18	$308.46
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	393	$307.58
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	129	$305.34
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,714	$278.26
81015		<1%	135	$276.38
29515		<1%	12	$272.78
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,265	$267.36
85007		<1%	82	$246.25
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	21	$244.74
84403		<1%	12	$241.28
87116		<1%	25	$238.44
82150		<1%	46	$236.32
S0077	Injection, clindamycin phosphate, 300 mg	<1%	19	$233.10
83001		<1%	13	$225.54
86780		<1%	572	$216.57
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	480	$215.08
80202		<1%	38	$213.47
51798		<1%	18	$207.84
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	12	$203.15
87015		<1%	72	$199.62
87449		<1%	48	$191.12
85045		<1%	65	$180.12
J0280	Injection, aminophyllin, up to 250 mg	<1%	73	$174.79
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	35	$172.88
J7070	Infusion, d5w, 1000 cc	<1%	103	$161.43
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	117	$154.84
C1788	Port, indwelling (implantable)	<1%	13	$151.53
97803		<1%	13	$147.24
84376		<1%	28	$141.66
APT06		<1%	13	$139.74
84480		<1%	13	$135.68
90686		<1%	13	$127.74
82805		<1%	16	$126.47
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	80	$126.27
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,068	$124.41
82043		<1%	25	$123.26
83986		<1%	40	$118.33
APT02		<1%	16	$113.60
J3360	Injection, diazepam, up to 5 mg	<1%	66	$111.53
86039		<1%	12	$103.71
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	1,604	$102.08
82533		<1%	15	$95.46
87324		<1%	34	$94.63
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	21	$90.18
84157		<1%	17	$86.98
87181		<1%	30	$73.64
85390		<1%	30	$59.06
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	279	$51.46
85576		<1%	15	$49.82
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	14	$49.59
84300		<1%	74	$49.44
84478		<1%	67	$35.52
A9270	Non-covered item or service	<1%	53,704	$22.38
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	18	$12.89
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	202	$10.03
J8540	Dexamethasone, oral, 0.25 mg	<1%	17	$8.44
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	14	$0.94
J1956	Injection, levofloxacin, 250 mg	0%	16	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	140	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	4,633	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	124	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	38	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	12	$0.00
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	133	$0.00
C1874	Stent, coated/covered, with delivery system	0%	30	$0.00
93798		0%	208	$0.00
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	61	$0.00
90935	Hemodialysis procedure with single evaluation by a physician	0%	598	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTEINES, BRIAN (CFO)